Evidence map›Paper›PMID 36353788›Full record

ArticleThe Korean journal of internal medicine2023

Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer.

Hyuk Yoon, Nam-Eun Kim, Jihye Park, Cheol Min Shin, Nayoung Kim, Dong Ho Lee, Jae Yong Park, Chang Hwan Choi, Jae Gyu Kim, Young Soo Park

Abstract read
In one paragraph

Article in The Korean journal of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Extracellular vesicles in laboratory medicine: a review and outlook.Frontiers in cell and developmental biology · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyuk YoonDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Nam-Eun KimDepartment of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Korea.
Jihye ParkDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Cheol Min ShinDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Nayoung KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Dong Ho LeeDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Jae Yong ParkDepartment of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Chang Hwan ChoiDepartment of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Jae Gyu KimDepartment of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Young Soo ParkDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Funding

Ministry of Science and ICTNational Research Foundation of Korea 2017M3A9F3047495Seoul National University Bundang Hospital 04-2012-004
6 · The paper itself

Abstract

BACKGROUND/

aimsWe evaluated the gut microbiome using extracellular vesicles (EVs) in the urine of patients with colorectal cancer (CRC) to determine whether gut-microbe-derived EVs could be a potential biomarker for the diagnosis of CRC.

methodsEVs were isolated from the urine of patients with CRC and healthy controls. DNA was extracted from the EVs, and the bacterial composition was analyzed using next-generation sequencing of the 16S rRNA.

resultsA total of 91 patients with CRC and 116 healthy controls were enrolled. We found some specific microbiomes that were more or less abundant in the CRC group than in the control group. The alpha-diversity of the gut microbiome was significantly lower in the CRC group than in the control group. A significant difference was observed in the beta-diversity between the groups. The alpha-diversity indices between patients with early- and late-stage CRC showed conflicting results; however, there was no significant difference in the beta-diversity according to the stage of CRC. There was no difference in the alpha- and beta-diversity of the gut microbiome corresponding to the location of CRC (proximal vs. distal).

conclusionA distinct gut microbiome is reflected in the urine EVs of patients with CRC compared with that in the healthy controls. Microbial signatures from EVs in urine could serve as potential biomarkers for the diagnosis of CRC.

Indexed as

Colorectal NeoplasmsExtracellular VesiclesGastrointestinal MicrobiomeBacteriaHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16SColorectal neoplasmsExtracellular vesiclesMicrobial diversityMicrobiotaUrine

Identifiers

PMID36353788
PMCPMC9816683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.